Chemical activators of V1RD17 utilize various mechanisms to enhance its activity through phosphorylation. Forskolin directly stimulates adenylyl cyclase, resulting in an increased concentration of intracellular cAMP. The rise in cAMP levels activates protein kinase A (PKA), which then phosphorylates V1RD17, leading to its activation. Similarly, IBMX raises intracellular cAMP and cGMP levels by inhibiting phosphodiesterases, thus preventing their breakdown. The sustained levels of these cyclic nucleotides continuously activate PKA and protein kinase G (PKG), which in turn can phosphorylate V1RD17. PGE2 functions through its EP receptors, which are G protein-coupled receptors that activate adenylyl cyclase to catalyze the formation of cAMP. Subsequently, PKA is activated and phosphorylates V1RD17. Moreover, Histamine, upon engaging with H2 receptors, and Epinephrine and Isoproterenol, through beta-adrenergic receptors, all stimulate adenylyl cyclase via Gs proteins, resulting in elevated cAMP and the activation of PKA, which phosphorylates V1RD17. Adenosine similarly increases cAMP levels through the activation of A2A receptors, leading to PKA-mediated phosphorylation of V1RD17.
On the other hand, Vardenafil acts through the inhibition of phosphodiesterase type 5, leading to enhanced cGMP levels, which activate PKG, and consequently, PKG phosphorylates V1RD17. NO Donors, like Sodium Nitroprusside, increase the levels of cGMP by stimulating guanylyl cyclase, which activates PKG, leading to the phosphorylation of V1RD17. Furthermore, Anisomycin activates stress-activated protein kinases, such as JNK, which can then phosphorylate V1RD17. Angiotensin II binds to the AT1 receptor, which activates phospholipase C and produces diacylglycerol (DAG) and inositol trisphosphate (IP3). DAG directly activates protein kinase C (PKC), which then phosphorylates and activates V1RD17. Each chemical thus facilitates the phosphorylation of V1RD17 through distinct yet convergent biochemical pathways, emphasizing the protein's role as a nexus in cellular signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) inhibits phosphodiesterases, preventing the breakdown of cAMP and cGMP. This results in the sustained activation of PKA and PKG, which can phosphorylate and lead to the activation of V1RD17. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) binds to its EP receptors, which are G protein-coupled receptors that can stimulate cAMP production via activation of adenylyl cyclase. The increase in cAMP activates PKA, which can phosphorylate and activate V1RD17. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil inhibits phosphodiesterase type 5, leading to an increase in cGMP levels. The elevated cGMP activates PKG, which then can phosphorylate and activate V1RD17. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium Nitroprusside, a nitric oxide donor, can stimulate guanylyl cyclase to produce cGMP, leading to the activation of PKG. PKG can then phosphorylate and lead to the activation of V1RD17. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can activate H2 receptors, which are coupled to Gs proteins that stimulate adenylyl cyclase, leading to an increase in cAMP. This rise in cAMP activates PKA, which can phosphorylate and activate V1RD17. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with beta-adrenergic receptors, leading to activation of Gs proteins and subsequent stimulation of adenylyl cyclase. The increase in cAMP activates PKA, which can phosphorylate and activate V1RD17. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a synthetic catecholamine, activates beta-adrenergic receptors, resulting in increased cAMP production and PKA activation. PKA then can phosphorylate and activate V1RD17. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine binding to A2A receptors leads to an increase in cAMP through Gs protein activation of adenylyl cyclase. The subsequent activation of PKA can lead to the phosphorylation and activation of V1RD17. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of stress-activated protein kinases, such as JNK. Activated JNK can phosphorylate target proteins, which can include V1RD17, leading to its activation. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II binds to its AT1 receptor, which activates Gq proteins and leads to the activation of phospholipase C, producing IP3 and DAG. This can stimulate the activation of PKC, which can then phosphorylate and activate V1RD17. | ||||||